Hi-Tech Pharmacal Co.’s (HITK) share price has entered into oversold territory with a stochastic value of 19.73. The Zacks Consensus Estimate on the company’s earnings for April 2011 increased by 32 cents over the past two months to $2.69 per share. Hi-Tech Pharmacal Co. is a Zacks #1 Rank (“Strong Buy”) company.
 
HI TECH PHARMA (HITK): Free Stock Analysis Report
 
Zacks Investment Research